MedPath

A prospective, multicenter, real world study of Yangzheng Xiaoji capsule in the treatment of cancer-related fatigue

Phase 4
Recruiting
Conditions
Malignant solid tumor
Registration Number
ITMCTR2100004751
Lead Sponsor
Department of Radiotherapy, the Second Affiliated Hospital, Xi'an Jiaotong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Patients diagnosed as malignant tumor (solid tumor) by pathology or cytology;
2.Patients with moderate to severe fatigue (4-10 points);
3.Clear mind, can objectively cooperate with the doctor to complete the examination and evaluation;
4.ECoG score of physical condition was 0-3;
5.Expected survival >= 3 months;
6.Aged 18-75 years;
7.Voluntary participation, signing informed consent, good compliance and cooperation with follow-up.

Exclusion Criteria

1.Patients with clinically significant liver dysfunction, i.e. glutamic oxaloacetic transaminase or alanine transaminase > 2.5 fold ULN, total serum bilirubin > 1.5 fold ULN;
2.Patients with clinically significant renal insufficiency, i.e. serum creatinine > 1.5 fold ULN;
3.Patients with severe heart disease, i.e. NYHA grade III-IV heart failure, unstable angina pectoris, myocardial infarction, underwent coronary artery reconstruction within 6 months before admission;
4.Patients with splenectomy or other serious hematopoietic system diseases;
5.Uncontrolled diabetes, hypertension (systolic blood pressure > 180mmhg and / or diastolic blood pressure > 120mmhg), uncontrollable infection, and severe peptic ulcer;
6.Mental patients without self-knowledge ability, those without legal capacity or limited legal capacity;
7.Patients who are pregnant, lactating or have the possibility of pregnancy and planned pregnancy;
8.Patients have participated in or are participating in other clinical studies in the past one month;
9.The researchers believe that there are any other unsuitable candidates. Determine other situations that may affect the clinical research and the interpretation of research results.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath